Zobrazeno 1 - 10
of 64
pro vyhledávání: '"J J, Petrie"'
Publikováno v:
Transplantation. 59(3)
Between January 1, 1982, and November 1, 1986, 169 cadaver renal graft transplantations were performed at this hospital with CsA as induction therapy. OKT3 was not available in this period. Of these grafts, 15.9% were lost within 6 months, 10.7% from
Publikováno v:
Clinical nephrology. 18(6)
A 34 year old female developed impaired function of her renal allograft 21 months post-transplant. This was associated with lethargy, pyrexia, tenosynovitis, pancytopenia and a colonic ulcer. Severe tubulo-interstitial changes with intranuclear inclu
Publikováno v:
Transplantation proceedings. 21(1 Pt 2)
Publikováno v:
The Journal of laboratory and clinical medicine. 114(4)
We investigated the growth of hyperplastic parathyroid glands removed at operation from 16 patients with chronic renal failure complicated by hypercalcemia, by incubating fresh tissue with tritiated thymidine. In each gland the proportion of cells sy
Autor:
R J, Rigby, J J, Petrie
Publikováno v:
Transplantation. 37(5)
Publikováno v:
Transplantation proceedings. 21(1 Pt 2)
Publikováno v:
Clinical science. 34(1)
Autor:
J J, Petrie
Publikováno v:
The Australasian nurses journal. 1(11)
Autor:
Araujo D; Hospital de Base, Sao Jose do Rio Preto, Brazil., Greystoke A; Northern Centre for Cancer Care, Newcastle, UK., Bates S; Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, USA., Bayle A; Institut Gustave Roussy, Paris, France., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Castelo-Branco L; European Society for Medical Oncology (ESMO), Lugano, Switzerland., de Bono J; Institute of Cancer Research, University of London, London; The Royal Marsden Hospital, London, UK., Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA., Garralda E; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ivy P; National Cancer Institute, USA Cancer Therapy Evaluation Program Investigational Drug Branch (NCI/CTEP/IDB), Bethesda, USA., Kholmanskikh O; European Medicines Agency, Amsterdam, Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium., Melero I; CUN and CIMA, University of Navarra, Pamplona, Spain., Pentheroudakis G; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Petrie J; Canadian Cancer Trials Group, Queen's University, Kingston., Plummer R; Northern Centre for Cancer Care, Newcastle, UK., Ponce S; Institut Gustave Roussy, Paris, France., Postel-Vinay S; Institut Gustave Roussy, Paris, France., Siu L; Princess Margaret Cancer Centre, Toronto, Canada., Spreafico A; Princess Margaret Cancer Centre, Toronto, Canada., Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Steeghs N; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Yap C; Institute of Cancer Research, University of London, London., Yap TA; Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center, Houston., Ratain M; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA., Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston. Electronic address: lseymour@ctg.queensu.ca.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Jan; Vol. 34 (1), pp. 48-60. Date of Electronic Publication: 2022 Sep 29.
Autor:
Hasan M; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom. Electronic address: m.hasan@sheffield.ac.uk., Bath PA; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom; The University of Sheffield, Information School, Sheffield, United Kingdom., Marincowitz C; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Sutton L; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Pilbery R; Yorkshire Ambulance Service NHS Trust, Research and Development, Wakefield, United Kingdom., Hopfgartner F; The University of Koblenz and Landau, Institute for Web Science and Technologies, Koblenz, Germany., Mazumdar S; The University of Sheffield, Information School, Sheffield, United Kingdom., Campbell R; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Stone T; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Thomas B; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Bell F; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Turner J; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Biggs K; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Petrie J; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom., Goodacre S; The University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom.
Publikováno v:
Computers in biology and medicine [Comput Biol Med] 2022 Dec; Vol. 151 (Pt A), pp. 106024. Date of Electronic Publication: 2022 Aug 28.